share_log
Breakings ·  Jun 25 21:01
IGC Pharma Inc: Expects to Begin a Phase 1 Trial for Tgr-63 in 2025
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment